Related Experiment Video
Updated: Apr 27, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
ATP-binding cassette transporter A1: key player in cardiovascular and metabolic disease at local and systemic level
1Division of Biopharmaceutics, Cluster BioTherapeutics, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands.
Insights
ATP-binding cassette transporter A1 (ABCA1) is crucial for preventing cardiovascular and metabolic diseases. MicroRNA regulation of ABCA1 offers new therapeutic targets for these conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- ATP-binding cassette transporter A1 (ABCA1) mediates cellular cholesterol efflux to apolipoprotein AI (apoAI), impacting HDL formation and function.
- ABCA1 plays a significant role in cardiovascular and metabolic health.
Purpose of the Study:
- To review recent advances and insights into the role of ABCA1 in cardiovascular and metabolic diseases.
- To explore findings from studies utilizing genetically engineered mice.
Main Methods:
- Review of studies on genetically engineered mice focusing on ABCA1 function.
- Analysis of research on ABCA1's role in cholesterol metabolism, atherosclerosis, and glucose tolerance.
Main Results:
- Liver-specific ABCA1 deletion did not impact macrophage reverse cholesterol transport or atherosclerosis.
- ABCA1 in the intestine aids dietary cholesterol packaging into HDL.
- ABCA1 in the arterial wall influences atherosclerosis via multiple cell types (bone marrow-derived, endothelial, smooth muscle).
- Adipocyte-specific ABCA1 prevents fat storage and improves glucose tolerance.
- Post-transcriptional regulation of ABCA1 by microRNAs is a key finding.
Conclusions:
- Recent research highlights ABCA1's importance in preventing cardiovascular and metabolic diseases.
- MicroRNA-mediated regulation of ABCA1 presents novel therapeutic targets for disease treatment.
Purpose Of Review:
ATP-binding cassette transporter A1 (ABCA1) facilitates cellular cholesterol efflux to lipid-poor apolipoprotein AI (apoAI) and plays a key role in the formation and function of HDL. This review summarizes the advances and new insights in the role of ABCA1 in cardiovascular and metabolic diseases from studies in genetically engineered mice.
Recent Findings:
Recent studies show that low HDL associated with liver-specific deletion of ABCA1 does not affect macrophage reverse cholesterol transport or atherosclerosis susceptibility. In the intestine, ABCA1 contributes to the packaging of dietary cholesterol into HDL. Locally in the arterial wall, ABCA1 influences atherosclerosis by acting not only in bone marrow-derived cells but also in endothelial cells and smooth muscle cells. Furthermore, other than its established role in regulating insulin secretion by β-cells, evidence is provided that adipocyte-specific ABCA1 prevents fat storage and the development of impaired glucose tolerance. Moreover, new insights are provided on the post-transcriptional regulation of ABCA1 expression by microRNAs.
Summary:
Recent studies underscore the importance of ABCA1 in the prevention of cardiovascular and metabolic diseases. Furthermore, the discovery of the extensive regulation of ABCA1 expression by microRNAs has unraveled novel therapeutic targets for ABCA1-based strategies for the treatment of these diseases.
More Related Videos
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
08:31Fluorescence Microscopy for ATP Internalization Mediated by Macropinocytosis in Human Tumor Cells and Tumor-xenografted Mice
Published on: June 30, 2021
Related Concept Videos
The ADP/ATP Carrier Protein
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
ABC Transporters: Exporter
ATP Driven Pumps I: An Overview
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
ATP Synthase: Mechanism
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...